Axis Capital Holdings Ltd. logo

Axis Capital Holdings Ltd. (AXS)

Market Closed
17 Dec, 21:00
NYSE NYSE
$
107. 06
-0.08
-0.07%
$
7.87B Market Cap
8.75 P/E Ratio
1.76% Div Yield
416,038 Volume
8.2 Eps
$ 107.14
Previous Close
Day Range
105.81 107.72
Year Range
83.9 108.12
Want to track AXS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 42 days
Is Axis Capital Holdings (AXS) Outperforming Other Finance Stocks This Year?

Is Axis Capital Holdings (AXS) Outperforming Other Finance Stocks This Year?

Here is how Axis Capital (AXS) and Aflac (AFL) have performed compared to their sector so far this year.

Zacks | 1 year ago
AXS or CINF: Which Is the Better Value Stock Right Now?

AXS or CINF: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Insurance - Property and Casualty sector have probably already heard of Axis Capital (AXS) and Cincinnati Financial (CINF). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 1 year ago
Should Value Investors Buy Axis Capital Holdings (AXS) Stock?

Should Value Investors Buy Axis Capital Holdings (AXS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Axsome Therapeutics Q3 Earnings: Stay For The Near Term Catalysts, Then Sell

Axsome Therapeutics Q3 Earnings: Stay For The Near Term Catalysts, Then Sell

Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m, up 81% YoY, but net loss increased to $(64.6m). Despite positive market response and promising pipeline candidates, Axsome's profitability remains distant, with significant cash burn and competition from pharma giants. AXS-07 is likely to gain FDA approval in January for migraine treatment, while AXS-05 shows potential for Alzheimer's agitation, but “blockbuster” revenue status is uncertain.

Seekingalpha | 1 year ago
Axis Capital Holdings Limited (AXS) Hits Fresh High: Is There Still Room to Run?

Axis Capital Holdings Limited (AXS) Hits Fresh High: Is There Still Room to Run?

Axis Capital (AXS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 1 year ago
AXS vs. CINF: Which Stock Is the Better Value Option?

AXS vs. CINF: Which Stock Is the Better Value Option?

Investors with an interest in Insurance - Property and Casualty stocks have likely encountered both Axis Capital (AXS) and Cincinnati Financial (CINF). But which of these two stocks is more attractive to value investors?

Zacks | 1 year ago
Are Investors Undervaluing Axis Capital Holdings (AXS) Right Now?

Are Investors Undervaluing Axis Capital Holdings (AXS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
AXIS Capital Holdings Limited (AXS) Q3 2024 Earnings Call Transcript

AXIS Capital Holdings Limited (AXS) Q3 2024 Earnings Call Transcript

AXIS Capital Holdings Limited (NYSE:AXS ) Q3 2024 Earnings Conference Call October 31, 2024 9:00 AM ET Company Participants Clifford Gallant - Investor Relations Vincent Tizzio - President and Chief Executive Officer Peter Vogt - Chief Financial Officer Conference Call Participants Andrew Kligerman - TD Cowen Dean Criscitiello - KBW Elyse Greenspan - Wells Fargo Operator Good day, and welcome to the AXIS Capital Third Quarter 2024 Earnings Call. All participants will be in listen-only mode.

Seekingalpha | 1 year ago
AXIS Capital Q3 Earnings and Revenues Beat, Premiums Rise Y/Y

AXIS Capital Q3 Earnings and Revenues Beat, Premiums Rise Y/Y

AXS' third-quarter results reflect improved net investment income and higher premiums, offset by poor underwriting income.

Zacks | 1 year ago
Axis Capital (AXS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Axis Capital (AXS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Axis Capital (AXS) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 1 year ago
Axis Capital (AXS) Q3 Earnings and Revenues Surpass Estimates

Axis Capital (AXS) Q3 Earnings and Revenues Surpass Estimates

Axis Capital (AXS) came out with quarterly earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.50 per share. This compares to earnings of $2.34 per share a year ago.

Zacks | 1 year ago
Should AXS Stock Be in Your Portfolio Ahead of Q3 Earnings?

Should AXS Stock Be in Your Portfolio Ahead of Q3 Earnings?

Axis Capital's third-quarter results are likely to gain from solid performance at both the segments.

Zacks | 1 year ago
Loading...
Load More